News

Fierce 50 Innovation Honoree, Eric Green, M.D., Ph.D.

Eric Green Honored as Fierce 50 Innovation Honoree

Eric Green, M.D., Ph.D., formerly the NHGRI director, has been awarded by Fierce Pharma as a Fierce 50 Innovation Honoree. The Fierce 50 is designed to honor the 50 most influential leaders and organizations shaping the future of biopharma, healthcare, and life sciences. The Fierce editorial team
More
Two people with megaphones holding a sign that says "we're hiring"

NIAID Technology Transfer and Intellectual Property Office - Senior Business Development Specialist Opening

Are you interested in making an impact on the improvement of global health? Are you interested in working in a dynamic organization that values its employees and offers work-life flexibility? The National Institute of Allergy and Infectious Diseases (NIAID), Technology Transfer and Intellectual
More
17th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation & Technology Transfer. Presenting: The NIH Dengue Vaccine: A Long Journey from Bench to Bedside. Stephen S. Whitehead, Ph.D., Senior Investigator, NIAID

Please Join Us for the 17th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer

The 17th Annual Philip S. Chen Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer will be held on Friday, September 25, 2024 at 10 a.m. ET in the Masur Auditorium in Building 10. The Chen lecture was established in 2006 by the NIH Deputy Director for Intramural Research and the
More
Attend the MedInvest Biotech & Pharma Investor Conference

Attend the MedInvest Biotech & Pharma Investor Conference to Learn About Licensing and Collaborating With the NIH

MedInvest is hosting a Biotech and Pharma Investor Conference September 18-19, 2024 in New York City. NIH’s Steve Ferguson and Michael Salgaller will be speaking. They will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions! This is
More